Speakers

Joachim Koch

VP of Translational Biology

Affimed

Mini Bharathan

VP, Development & Translational Medicine

Arovella

Katharina Filarsky

Head of Assays 3 in Biologics Research

Bayer AG

Ioana Panait

Researcher

Beacon Targeted Therapeutics

Sharon Longhurst

VP of Development

Gadeta

Aviad Pato

Head of NK Research

Gamida Cell

Kai Pinkernell

CMO

Glycostem Therapeutics B.V.

Volker Huppert

CDO

Glycostem Therapeutics B.V.

Mark Lowdell

CSO

INmune Bio, Inc.

Kate Rochlin

COO

IN8bio

Robert Igarashi

Head of Discovery & Pre-Clinical Development

Kiadis, a Sanofi Company

Evren Alici

Group Leader, Associate Professor

Karolinska Institutet

Michael Uhlin

Professor, Head of Development & IT, Department of Clinical Immunology

Karolinska Institutet & Karolinska University Hospital

Niklas Björkström

Associate Professor, MD PhD

Karolinska Institutet

Hans van der Vliet

CSO

Lava Therapeutics

Marc van Dijk

CSO

MiNK Therapeutics

Donald Shaffer

Head of Precision Cytokines & Cell Therapies

Sanofi

Michael Leek

Executive Chairman & Founder

TC Biopharm

Angela Scott

COO & Founder

TC Biopharm

Jonathan Fisher

Group Leader

University College London

Marta Barisa

Senior Fellow & Scientific Project Manager

University College London

Lulu Chu

Associate Director, Cell Therapy Clinical Pharmacology & Modeling

Takeda

Namir Hassan

CEO

Zelluna Immunotherapy AS

Dan Kemp

CEO

Wugen